| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.15e-04 | 46 | 41 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.47e-04 | 9 | 41 | 2 | GO:0010854 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 6.16e-04 | 18 | 41 | 2 | GO:0010851 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 9.41e-06 | 67 | 41 | 4 | GO:1902692 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 1.16e-05 | 3 | 41 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 5.35e-05 | 104 | 41 | 4 | GO:0007405 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 8.04e-05 | 7 | 41 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 1.07e-04 | 8 | 41 | 2 | GO:2000809 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 1.11e-04 | 47 | 41 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | terminal button organization | 1.38e-04 | 9 | 41 | 2 | GO:0072553 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.38e-04 | 9 | 41 | 2 | GO:0003339 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.47e-04 | 135 | 41 | 4 | GO:2000177 | |
| GeneOntologyBiologicalProcess | pronephros development | 1.72e-04 | 10 | 41 | 2 | GO:0048793 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 1.98e-04 | 57 | 41 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition involved in metanephros morphogenesis | 2.51e-04 | 12 | 41 | 2 | GO:0003337 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 2.51e-04 | 12 | 41 | 2 | GO:2000807 | |
| GeneOntologyBiologicalProcess | synaptic vesicle localization | 3.79e-04 | 71 | 41 | 3 | GO:0097479 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 3.98e-04 | 15 | 41 | 2 | GO:0072283 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 5.02e-04 | 334 | 41 | 5 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 5.02e-04 | 334 | 41 | 5 | GO:0001894 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 5.39e-04 | 80 | 41 | 3 | GO:2000179 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 5.78e-04 | 18 | 41 | 2 | GO:0072077 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 6.45e-04 | 19 | 41 | 2 | GO:2000696 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 6.45e-04 | 19 | 41 | 2 | GO:0072087 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition | 7.16e-04 | 20 | 41 | 2 | GO:0060231 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 8.16e-04 | 212 | 41 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of vesicle size | 8.68e-04 | 22 | 41 | 2 | GO:0097494 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 8.68e-04 | 22 | 41 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | dorsal spinal cord development | 8.68e-04 | 22 | 41 | 2 | GO:0021516 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 8.68e-04 | 22 | 41 | 2 | GO:0097091 | |
| GeneOntologyBiologicalProcess | positive regulation of branching involved in ureteric bud morphogenesis | 8.68e-04 | 22 | 41 | 2 | GO:0090190 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 7.48e-06 | 139 | 41 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.19e-05 | 153 | 41 | 5 | GO:0097731 | |
| GeneOntologyCellularComponent | non-motile cilium | 3.92e-05 | 196 | 41 | 5 | GO:0097730 | |
| GeneOntologyCellularComponent | collagen trimer | 6.85e-04 | 88 | 41 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 7.70e-04 | 21 | 41 | 2 | GO:0098644 | |
| MousePheno | postnatal lethality | CPEB2 COL4A2 MAGI2 LHX5 TAB1 GNAS COL17A1 TCF20 ATN1 PAX8 PICALM POLR2A | 2.43e-05 | 1084 | 39 | 12 | MP:0002082 |
| Domain | Collagen | 6.84e-04 | 85 | 38 | 3 | PF01391 | |
| Domain | Collagen | 6.84e-04 | 85 | 38 | 3 | IPR008160 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.40e-04 | 41 | 35 | 3 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.73e-04 | 44 | 35 | 3 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.57e-04 | 61 | 35 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.57e-04 | 61 | 35 | 3 | MM14637 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A2 COL5A1 SMARCD3 HNF1A ADGRV1 SALL1 ROBO3 PAX8 PKP3 ZNF335 POLR2A | 4.76e-04 | 1432 | 35 | 11 | M509 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.27e-04 | 64 | 35 | 3 | M26953 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 5.76e-04 | 66 | 35 | 3 | M39684 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.02e-04 | 67 | 35 | 3 | M26999 | |
| Pathway | WP_ID_SIGNALING | 7.03e-04 | 16 | 35 | 2 | M39359 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 34480849 | ||
| Pubmed | 3.88e-06 | 26 | 41 | 3 | 29712641 | ||
| Pubmed | Structure and function of the human transcription elongation factor DSIF. | 4.06e-06 | 3 | 41 | 2 | 10075709 | |
| Pubmed | The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. | 4.06e-06 | 3 | 41 | 2 | 16330323 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 24191038 | ||
| Pubmed | Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA. | 4.06e-06 | 3 | 41 | 2 | 24814348 | |
| Pubmed | Yeast screens identify the RNA polymerase II CTD and SPT5 as relevant targets of BRCA1 interaction. | 4.06e-06 | 3 | 41 | 2 | 18197258 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 9450929 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 15355349 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 7.24e-06 | 877 | 41 | 8 | 20211142 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 12391174 | ||
| Pubmed | The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. | 8.12e-06 | 4 | 41 | 2 | 11575923 | |
| Pubmed | 1.25e-05 | 38 | 41 | 3 | 27820600 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 11940650 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 35325203 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 14580347 | ||
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 2.03e-05 | 6 | 41 | 2 | 9647693 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 36476876 | ||
| Pubmed | 2.38e-05 | 47 | 41 | 3 | 15172686 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 2.44e-05 | 1038 | 41 | 8 | 26673895 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 3.70e-05 | 321 | 41 | 5 | 32098917 | |
| Pubmed | Tat-SF1 protein associates with RAP30 and human SPT5 proteins. | 3.78e-05 | 8 | 41 | 2 | 10454543 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 10199401 | ||
| Pubmed | Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. | 3.78e-05 | 8 | 41 | 2 | 23064645 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 16327805 | ||
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 12612062 | ||
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 5.48e-05 | 62 | 41 | 3 | 28344315 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.66e-05 | 351 | 41 | 5 | 38297188 | |
| Pubmed | DYRK3 phosphorylates SNAPIN to regulate axonal retrograde transport and neurotransmitter release. | 6.07e-05 | 10 | 41 | 2 | 36585413 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 21880767 | ||
| Pubmed | In vivo role of different domains and of phosphorylation in the transcription factor Nkx2-1. | 6.07e-05 | 10 | 41 | 2 | 21345181 | |
| Pubmed | 6.37e-05 | 591 | 41 | 6 | 15231748 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 23652018 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 31045206 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 16916509 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 17300925 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 8.37e-05 | 908 | 41 | 7 | 19274049 | |
| Pubmed | Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits. | 8.88e-05 | 12 | 41 | 2 | 17110384 | |
| Pubmed | Netrin1/DCC signaling promotes neuronal migration in the dorsal spinal cord. | 8.88e-05 | 12 | 41 | 2 | 27784329 | |
| Pubmed | 8.92e-05 | 199 | 41 | 4 | 23382691 | ||
| Pubmed | 1.00e-04 | 205 | 41 | 4 | 20436479 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.02e-04 | 398 | 41 | 5 | 35016035 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 17166926 | ||
| Pubmed | 1.21e-04 | 963 | 41 | 7 | 28671696 | ||
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 1.22e-04 | 14 | 41 | 2 | 8895581 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 9891079 | ||
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 11809800 | ||
| Pubmed | 1.47e-04 | 430 | 41 | 5 | 32581705 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 27223328 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 22307612 | ||
| Pubmed | Domains in the SPT5 protein that modulate its transcriptional regulatory properties. | 1.61e-04 | 16 | 41 | 2 | 10757782 | |
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 17881772 | ||
| Pubmed | 1.61e-04 | 16 | 41 | 2 | 25617721 | ||
| Pubmed | A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. | 1.82e-04 | 17 | 41 | 2 | 10393184 | |
| Pubmed | 1.82e-04 | 17 | 41 | 2 | 10958691 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 11112772 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 20471948 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 26658320 | ||
| Pubmed | 2.60e-04 | 263 | 41 | 4 | 34702444 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.76e-04 | 774 | 41 | 6 | 15302935 | |
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 28760814 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 21300955 | ||
| Pubmed | A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. | 3.09e-04 | 22 | 41 | 2 | 19483677 | |
| Pubmed | Conserved and Divergent Molecular and Anatomic Features of Human and Mouse Nephron Patterning. | 3.09e-04 | 22 | 41 | 2 | 29449451 | |
| Pubmed | Cbln1 regulates axon growth and guidance in multiple neural regions. | 3.09e-04 | 22 | 41 | 2 | 36395107 | |
| Pubmed | p63 exerts spatio-temporal control of palatal epithelial cell fate to prevent cleft palate. | 3.68e-04 | 24 | 41 | 2 | 28604778 | |
| Pubmed | Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. | 3.68e-04 | 24 | 41 | 2 | 17036046 | |
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 21784065 | ||
| Pubmed | Isolation and characterization of a human cDNA for mRNA 5'-capping enzyme. | 4.00e-04 | 25 | 41 | 2 | 9512541 | |
| Pubmed | 4.00e-04 | 25 | 41 | 2 | 9790902 | ||
| Pubmed | 4.27e-04 | 300 | 41 | 4 | 10591208 | ||
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.33e-04 | 26 | 41 | 2 | 34162889 | |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 4.33e-04 | 26 | 41 | 2 | 33298525 | |
| Pubmed | Characterization of a novel Lbx1 mouse loss of function strain. | 4.33e-04 | 26 | 41 | 2 | 34906895 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 4.62e-04 | 552 | 41 | 5 | 10737800 | |
| Pubmed | 4.90e-04 | 130 | 41 | 3 | 12421765 | ||
| Pubmed | 5.03e-04 | 28 | 41 | 2 | 33953184 | ||
| Pubmed | TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. | 5.03e-04 | 28 | 41 | 2 | 29653964 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 5.14e-04 | 565 | 41 | 5 | 25468996 | |
| Pubmed | Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. | 5.71e-04 | 137 | 41 | 3 | 30862715 | |
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 24440154 | ||
| Pubmed | 6.58e-04 | 32 | 41 | 2 | 23154389 | ||
| Pubmed | An Approach to Spatiotemporally Resolve Protein Interaction Networks in Living Cells. | 6.58e-04 | 32 | 41 | 2 | 28388416 | |
| Pubmed | 6.91e-04 | 1285 | 41 | 7 | 35914814 | ||
| Pubmed | 7.00e-04 | 33 | 41 | 2 | 12676794 | ||
| Pubmed | 7.37e-04 | 347 | 41 | 4 | 17114649 | ||
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 7.43e-04 | 34 | 41 | 2 | 20834067 | |
| Pubmed | 7.72e-04 | 152 | 41 | 3 | 34299191 | ||
| Pubmed | 7.87e-04 | 153 | 41 | 3 | 25037231 | ||
| Pubmed | 8.33e-04 | 36 | 41 | 2 | 22422068 | ||
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 22797727 | ||
| Pubmed | A RECQ5-RNA polymerase II association identified by targeted proteomic analysis of human chromatin. | 8.80e-04 | 37 | 41 | 2 | 18562274 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 9.25e-04 | 974 | 41 | 6 | 28675297 | |
| Pubmed | 9.85e-04 | 653 | 41 | 5 | 22586326 | ||
| Pubmed | 9.93e-04 | 376 | 41 | 4 | 24154525 | ||
| Pubmed | 9.98e-04 | 655 | 41 | 5 | 35819319 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.00e-03 | 377 | 41 | 4 | 38117590 | |
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 27068110 | ||
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 31152445 | ||
| Pubmed | 1.13e-03 | 42 | 41 | 2 | 27780869 | ||
| Interaction | CRX interactions | 1.17e-05 | 254 | 41 | 6 | int:CRX | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 2.37e-04 | 330 | 42 | 4 | chr22q13 | |
| Cytoband | 19q13 | 3.74e-04 | 31 | 42 | 2 | 19q13 | |
| Cytoband | 22q13.1 | 2.78e-03 | 85 | 42 | 2 | 22q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q12 | 4.05e-03 | 103 | 42 | 2 | chr16q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20q13 | 6.79e-03 | 422 | 42 | 3 | chr20q13 | |
| GeneFamily | Collagens | 3.41e-05 | 46 | 25 | 3 | 490 | |
| Coexpression | PGF_UP.V1_DN | 1.30e-05 | 190 | 42 | 5 | M2673 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 3.23e-05 | 574 | 42 | 7 | M39056 | |
| Coexpression | JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN | 4.20e-05 | 42 | 42 | 3 | M16561 | |
| Coexpression | NABA_COLLAGENS | 4.52e-05 | 43 | 42 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 4.84e-05 | 44 | 42 | 3 | M3005 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 4.95e-05 | 126 | 42 | 4 | M39132 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_100 | 1.24e-06 | 98 | 41 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 6.77e-05 | 41 | 41 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K2 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-08 | 186 | 42 | 6 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-08 | 189 | 42 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-07 | 180 | 42 | 5 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.80e-07 | 191 | 42 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | lymphoid-T_cell-pro-T_cell|lymphoid / Lineage, cell class and subclass | 2.22e-06 | 98 | 42 | 4 | 4da11182885d5f2673e85bd9c5717939b0268427 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.49e-06 | 133 | 42 | 4 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 1.48e-05 | 158 | 42 | 4 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 162 | 42 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 162 | 42 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-05 | 162 | 42 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 2.11e-05 | 173 | 42 | 4 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 177 | 42 | 4 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 177 | 42 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 179 | 42 | 4 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 182 | 42 | 4 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.80e-05 | 186 | 42 | 4 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.80e-05 | 186 | 42 | 4 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.80e-05 | 186 | 42 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-05 | 187 | 42 | 4 | 9225caf66e06ebe57e90d677122acb6498607f36 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-05 | 188 | 42 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 191 | 42 | 4 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 42 | 4 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 193 | 42 | 4 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-05 | 195 | 42 | 4 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-05 | 195 | 42 | 4 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-05 | 196 | 42 | 4 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | droplet-Heart-HEART|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 197 | 42 | 4 | 9654472f1d4c9a6caadf1ff61a84902d171e9eb4 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 3.50e-05 | 197 | 42 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.50e-05 | 197 | 42 | 4 | 1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.50e-05 | 197 | 42 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.50e-05 | 197 | 42 | 4 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.50e-05 | 197 | 42 | 4 | d8355f07a53e771052f9ab6b38814365dfe8d9ae | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.50e-05 | 197 | 42 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | droplet-Heart-HEART-1m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-05 | 197 | 42 | 4 | 1ec3c05a5d4163df2cf0d168e28a3f1d35364da2 | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 3.50e-05 | 197 | 42 | 4 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-05 | 198 | 42 | 4 | 38b37daf41d84e5bf913eb3f72963418b7c0aac6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.64e-05 | 199 | 42 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 200 | 42 | 4 | ae91dc047dc80560ba298d8d21a772154fa2775d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 139 | 42 | 3 | 4efab4421e3448880a1dcf981f6a65131b038010 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.03e-04 | 139 | 42 | 3 | 39f3c28f89c37bb8cc049c56d2948ea906fb3d86 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 4.33e-04 | 157 | 42 | 3 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 158 | 42 | 3 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 4.49e-04 | 159 | 42 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.58e-04 | 160 | 42 | 3 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | lymphoid-T_cell-pro-T_cell|T_cell / Lineage, cell class and subclass | 4.58e-04 | 160 | 42 | 3 | 66fe86d2f37983761141e5bb3de127f0b4bb0951 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-04 | 162 | 42 | 3 | bfaeff19bb56598fdc8c82be71d51787cf13928f | |
| ToppCell | AT1-AT2_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.75e-04 | 162 | 42 | 3 | 57d627259d27f39885bf416d74bcb6656db6e27b | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 4.92e-04 | 164 | 42 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.01e-04 | 165 | 42 | 3 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 168 | 42 | 3 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 168 | 42 | 3 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-04 | 169 | 42 | 3 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 169 | 42 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 169 | 42 | 3 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-04 | 169 | 42 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-04 | 171 | 42 | 3 | 1efce222989460bb59bd9fa955e7d9a60c73994c | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-04 | 171 | 42 | 3 | 2dfed6e9ac89adb2501a1a5e1ca895f49190562d | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-plasmacytoid_dendritic_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.55e-04 | 171 | 42 | 3 | 2aaae0229c3a13d0275a03a3d576db650c2bf2c0 | |
| ToppCell | AT1-AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.55e-04 | 171 | 42 | 3 | 0b9912f07393aca889db72b40da08e0bc9bc1e8c | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 173 | 42 | 3 | 8fb32a9f2dbec16de840d55b4db7e7718f5a2a7a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-04 | 173 | 42 | 3 | f663571aaae2365660a8b526c355f4bd1a124a74 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-04 | 174 | 42 | 3 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.84e-04 | 174 | 42 | 3 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.94e-04 | 175 | 42 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-04 | 175 | 42 | 3 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.94e-04 | 175 | 42 | 3 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 176 | 42 | 3 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-04 | 176 | 42 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-04 | 176 | 42 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.04e-04 | 176 | 42 | 3 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.04e-04 | 176 | 42 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 177 | 42 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-04 | 177 | 42 | 3 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-04 | 177 | 42 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.14e-04 | 177 | 42 | 3 | 928118b0ed120ec01c7d753ce523ab609ac24e5f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-04 | 177 | 42 | 3 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 178 | 42 | 3 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 178 | 42 | 3 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-04 | 178 | 42 | 3 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.24e-04 | 178 | 42 | 3 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.34e-04 | 179 | 42 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-04 | 179 | 42 | 3 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-04 | 180 | 42 | 3 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.45e-04 | 180 | 42 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-04 | 180 | 42 | 3 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-04 | 180 | 42 | 3 | df60970520fba2ac0639faa54096766d07418ca4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-04 | 181 | 42 | 3 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-04 | 181 | 42 | 3 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-04 | 181 | 42 | 3 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.55e-04 | 181 | 42 | 3 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 6.55e-04 | 181 | 42 | 3 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; HL60; HT_HG-U133A | 1.28e-06 | 195 | 41 | 6 | 3038_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 1.36e-06 | 197 | 41 | 6 | 4337_DN | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.40e-06 | 198 | 41 | 6 | 3990_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; PC3; HT_HG-U133A | 1.40e-06 | 198 | 41 | 6 | 3987_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HG-U133A | 1.44e-06 | 199 | 41 | 6 | 638_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.44e-06 | 199 | 41 | 6 | 4016_DN | |
| Drug | Sulfameter [651-06-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.44e-06 | 199 | 41 | 6 | 6212_UP | |
| Drug | C2SI | 6.05e-06 | 20 | 41 | 3 | CID006327160 | |
| Drug | GTX8 | 1.92e-05 | 29 | 41 | 3 | CID000104985 | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 2.14e-05 | 188 | 41 | 5 | 4456_DN | |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 2.37e-05 | 192 | 41 | 5 | 7062_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.37e-05 | 192 | 41 | 5 | 4342_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.43e-05 | 193 | 41 | 5 | 7490_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.43e-05 | 193 | 41 | 5 | 5922_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 2.43e-05 | 193 | 41 | 5 | 2682_UP | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.43e-05 | 193 | 41 | 5 | 6717_UP | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.49e-05 | 194 | 41 | 5 | 3245_UP | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.49e-05 | 194 | 41 | 5 | 4110_UP | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; HL60; HT_HG-U133A | 2.49e-05 | 194 | 41 | 5 | 1858_DN | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.55e-05 | 195 | 41 | 5 | 3542_UP | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A | 2.55e-05 | 195 | 41 | 5 | 3028_UP | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 3844_DN | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 5462_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.62e-05 | 196 | 41 | 5 | 7257_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.68e-05 | 197 | 41 | 5 | 6105_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 4081_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 4669_DN | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | 2.75e-05 | 198 | 41 | 5 | 594_UP | |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 5686_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; PC3; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 4087_DN | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; HL60; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 2409_UP | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; PC3; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 7548_DN | |
| Drug | SC45647 | 4.04e-05 | 37 | 41 | 3 | CID005289342 | |
| Drug | Sp 1 (pharmaceutical) | 4.98e-05 | 548 | 41 | 7 | CID000099040 | |
| Drug | panobinostat | KIAA1549 MAGI2 SEC24D GNAS ADGRV1 PMEPA1 NHSL2 POLR2A SYNGR1 PDE4DIP | 9.66e-05 | 1333 | 41 | 10 | ctd:C496932 |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.45e-04 | 170 | 41 | 4 | 5021_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.74e-04 | 175 | 41 | 4 | 1006_UP | |
| Drug | AC1O43PA | 2.84e-04 | 14 | 41 | 2 | CID006323294 | |
| Drug | resveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.38e-04 | 185 | 41 | 4 | 841_UP | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 3.45e-04 | 186 | 41 | 4 | 2684_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 3.45e-04 | 186 | 41 | 4 | 4271_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 3.45e-04 | 186 | 41 | 4 | 6672_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A | 3.59e-04 | 188 | 41 | 4 | 5921_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 5674_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 4274_UP | |
| Drug | Propantheline bromide [50-34-0]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.74e-04 | 190 | 41 | 4 | 3352_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.81e-04 | 191 | 41 | 4 | 7538_UP | |
| Drug | cyclosporine A; Up 200; 1uM; MCF7; HG-U133A | 3.81e-04 | 191 | 41 | 4 | 261_UP | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 3.81e-04 | 191 | 41 | 4 | 7542_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 4334_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 2699_DN | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 5620_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; HL60; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 1337_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.89e-04 | 192 | 41 | 4 | 4268_UP | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 4226_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.97e-04 | 193 | 41 | 4 | 4245_DN | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 5384_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3988_DN | |
| Drug | 17-AAG; Up 200; 1uM; SKMEL5; HG-U133A | 4.04e-04 | 194 | 41 | 4 | 505_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 6835_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 7352_UP | |
| Drug | Vincamine [1617-90-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 4341_DN | |
| Drug | Skimmianine [83-95-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 6066_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 5610_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 3384_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 2687_UP | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.04e-04 | 194 | 41 | 4 | 5695_UP | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 4957_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.12e-04 | 195 | 41 | 4 | 1015_UP | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 1uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 3735_DN | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 6424_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 6215_UP | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 4.12e-04 | 195 | 41 | 4 | 596_UP | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 4611_DN | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 4705_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 4326_DN | |
| Drug | Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 3871_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 1162_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 4.12e-04 | 195 | 41 | 4 | 5969_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 4114_UP | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 2628_UP | |
| Drug | 5162773; Down 200; 7uM; MCF7; HT_HG-U133A_EA | 4.20e-04 | 196 | 41 | 4 | 892_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 3716_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7346_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7470_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.20e-04 | 196 | 41 | 4 | 990_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 6027_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 5593_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7477_DN | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 7335_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 1684_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.20e-04 | 196 | 41 | 4 | 5499_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.20e-04 | 196 | 41 | 4 | 1054_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2889_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 2668_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 7486_DN | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3048_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 3620_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 4714_DN | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 4.29e-04 | 197 | 41 | 4 | 5948_DN | |
| Disease | Global developmental delay | 3.51e-05 | 133 | 41 | 4 | C0557874 | |
| Disease | blood urea nitrogen measurement | 3.57e-05 | 452 | 41 | 6 | EFO_0004741 | |
| Disease | Ischemic stroke, fibrinogen measurement | 6.21e-05 | 55 | 41 | 3 | EFO_0004623, HP_0002140 | |
| Disease | fibrinogen measurement, factor VII measurement | 7.29e-05 | 58 | 41 | 3 | EFO_0004619, EFO_0004623 | |
| Disease | serum urea measurement | 1.55e-04 | 195 | 41 | 4 | EFO_0009795 | |
| Disease | Generalized hypotonia | 1.96e-04 | 15 | 41 | 2 | C1858120 | |
| Disease | cystatin C measurement | 2.29e-04 | 402 | 41 | 5 | EFO_0004617 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 2.53e-04 | 17 | 41 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 2.53e-04 | 17 | 41 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 2.53e-04 | 17 | 41 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 2.53e-04 | 17 | 41 | 2 | C0751780 | |
| Disease | May-White Syndrome | 2.53e-04 | 17 | 41 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 2.53e-04 | 17 | 41 | 2 | C0751781 | |
| Disease | Feeding difficulties | 2.84e-04 | 18 | 41 | 2 | C0232466 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 2.84e-04 | 18 | 41 | 2 | C0751779 | |
| Disease | tyrosine measurement | 4.11e-04 | 104 | 41 | 3 | EFO_0005058 | |
| Disease | N-glycan measurement | 4.28e-04 | 22 | 41 | 2 | EFO_0004999 | |
| Disease | renal system measurement, blood urea nitrogen measurement | 4.28e-04 | 22 | 41 | 2 | EFO_0004741, EFO_0004742 | |
| Disease | IGF-1 measurement | 5.56e-04 | 488 | 41 | 5 | EFO_0004627 | |
| Disease | cognitive function measurement | 6.94e-04 | 1434 | 41 | 8 | EFO_0008354 | |
| Disease | hyperuricemia | 9.68e-04 | 33 | 41 | 2 | EFO_0009104 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 1.03e-03 | 34 | 41 | 2 | EFO_0004458, EFO_0004612 | |
| Disease | Sclerocystic Ovaries | 1.06e-03 | 144 | 41 | 3 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.06e-03 | 144 | 41 | 3 | C0032460 | |
| Disease | Developmental delay (disorder) | 1.22e-03 | 37 | 41 | 2 | C0424605 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSTMYVSGPPGPPGP | 986 | Q9UMD9 | |
| PTLSPMYPSGGGGPS | 281 | P50548 | |
| LPTSDMLGPAPYDPG | 381 | Q96LX7 | |
| TMAEGGVPSPGPGAY | 41 | A0A1B0GUV1 | |
| AMSPSLGSLRPYPPG | 531 | P54259 | |
| GPSTAFFTPGSGMPP | 6176 | Q8WXG9 | |
| PGLPGMPGRSVSIGY | 1476 | P08572 | |
| GETSVPPPPAVGRMY | 431 | Q8WWM7 | |
| LSGREMVGPTLPGYP | 361 | Q06710 | |
| YEDYGMTPPTGPLPR | 1751 | Q9HCM3 | |
| NDSPSDGGTPGRMPP | 686 | Q08999 | |
| GMGLPLPQDPYPSSD | 576 | Q86T65 | |
| GDGPPGPSSPMSRSQ | 711 | Q8WXD9 | |
| SMPTDGQLDGTYPPP | 571 | Q86UL8 | |
| PTVPDSPGYMGPTRA | 596 | Q765P7 | |
| MGEVPPYSGPRTPDG | 296 | P16499 | |
| MATAPSYPAGLPGSP | 1 | Q9BZL6 | |
| LAMDTYSGPPPGPGP | 281 | P20823 | |
| GEVFSGGPSPPFPMS | 366 | Q9H2C1 | |
| GGPSPPFPMSGTSGY | 371 | Q9H2C1 | |
| SGGRMEGPPPTYSEV | 221 | Q969W9 | |
| MPPPSPDSENGFYPG | 1 | Q7Z5Q1 | |
| AGFEDPPMRGPETTP | 696 | Q5THR3 | |
| PAAGPTGPEPMPSYA | 6 | P27544 | |
| YDPTSSPSEIGPGMP | 421 | P20908 | |
| PTSTGIPYGMSIPPE | 521 | Q9NSC2 | |
| RAMLDSGIYPPGSPG | 121 | O95295 | |
| GYPLGEMSQPTPSPA | 366 | Q15750 | |
| SPGRPPGLMSPSSGY | 701 | Q5HYW2 | |
| GSRGGYSPPPEETMP | 211 | Q5JWF2 | |
| PGSPYMGSPAVRPGL | 46 | Q6STE5 | |
| SPVGYSPMTPGAPSP | 946 | O00267 | |
| SPMTPGAPSPGGYNP | 951 | O00267 | |
| SYGSGMAPPSQGPPG | 131 | O94855 | |
| PEGPPGTSPSEFYFM | 106 | Q9Y242 | |
| PATTPTGMIGYGIPP | 601 | Q13492 | |
| AGYGGAQPTPPMPTR | 146 | Q9Y446 | |
| ASSRPPMGLGPAPYS | 946 | Q96MS0 | |
| GPSSPYIPSPGGAMS | 1576 | P24928 | |
| EPTGPDPAGMGGTYQ | 201 | O43759 | |
| SGPPGMSSQKRYGPP | 1201 | Q9UGU0 | |
| SPEPGPTAPYLGRSM | 621 | Q9C0B5 | |
| APPMEEGTSAPGTPY | 886 | Q9H4Z2 | |
| PSFSPPSPMGGDSNR | 986 | Q5VU43 |